Published in Mental Health Weekly Digest, May 31st, 2010
"Outpatients 18 years or older with MDD received desvenlafaxine 50, 100, 200, or 400 mg/d (men=709; women=1096) or placebo (men=399; women=709) for 8 weeks. Data were analyzed by sex and by age groups of 40 years and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.